Cite
HARVARD Citation
Burn, C. et al. (2018). A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2. Journal of infectious diseases. pp. 754-758. [Online].